Jose Alan De la Rosa Vazquez

J-1 VISA WAIVER (NEEDED)

Experienced healthcare professional with proven track record in patient care, diagnostics, and treatment planning. Strong focus on collaborative teamwork to ensure optimal patient outcomes, adapting seamlessly to changing clinical needs.

Accomplished General practitioner with 5 years of experience of combined training in residency, research/clinical and private practice.

In-Training Examination (ITE) PGY-1:94th. PGY-2: 76th. 

American Gastroenterological Association (AGA) Research Foundation abstract award: Abstract Award for Health Disparities Research. 

• American Heart Association: Council Member; Council of Clinical Cardiology (CLCD) Member; National Hispanic Latino Cardiovascular Collaborative (NHLCC)
• American College of Cardiology

• Peer-Reviewed Journal Articles
• Polypill Strategy in Secondary Cardiovascular Prevention. Alan De la Rosa, Arrington, Kedzie, Rohan Desai, Acharya, Prakarti. Current Cardiology Reports (2024). Current cardiology reports,10.1007/s11886-024-02046-1. Advance online publication PMID:38557814
• Weight Loss and Cardiovascular Disease Risk Outcomes of Semaglutide: A One-year Multicentered Cohort Study. Ghusn W, Fansa S, Anazco D, Tama E, Nicolalde B, Gala K, De la Rosa A, Sacoto D, Cifuentes L, Campos A, Feres F, Hurtado MD, Acosta A. Int J Obes (Lond).2024 Feb1. doi:10.1038/s41366-023-01456-5. Epub ahead of print. PMID:38302591.
• The association between previous use of anti-obesity medication and semaglutide weight loss outcomes. Ghusn W, Fansa S, Anazco D, Tama E, Cifuentes L, Gala K, De la Rosa A, Sacoto D, Campos A, Feris F, Hurtado D, Acosta A. Diabetes Obes Metab.2024 Mar12. doi:10.1111/dom.15523. Epub ahead of print. PMID:38469598.
• Phenotype tailored lifestyle intervention on weight loss and cardiometabolic risk factors in adults with obesity: a singlecentre, non-randomised, proof-of-concept study. Lizeth Cifuentes, Ghusn W, Fauzi Feris, Alejandro Campos, Daniel Sacoto, Alan De la Rosa, Maria D Hurtado, Matthew M Clark, Michael Camilleri, Donald D Hensrud, Andres Acosta. eClinical Medicine, The Lancet Discovery Science (2023) PMID:37070714
• Effect of Heterozygous Gene Variants of the Leptin-Melanocortin Pathway on Weight Loss Following Sleeve Gastrectomy. Fauzi Feris, Wissam Ghusn, Alejandro Campos, Lizeth Cifuentes, Alan De la Rosa, et al.Michael Camilleri, Andres Acosta. Obesity Surgery (2023). PMID:37166377.
• Refractory Escherichia Coli Pneumonia: A Case Report. Seyed A Khalafi1, Alan De La Rosa Vazquez2, Fatma Dihowm. Cures. (2023)PMID:36968935
• A comparison between weight loss outcomes with anti-obesity medications before and during Covid-19 pandemic at a tertiary weight management center. Obesity Pillars (2022). Alan De la Rosa, Wissam Ghusn, Daniel Sacoto, Alejandro Campos, Lizeth Cifuentes, Fauzi Feris, Bradley Busbee, Gerardo Calderon, Andres Acosta, Maria D. Hurtado. DOI: https://doi.org/10.1016/j.obpill.2022.100046
• Cardiovascular Risk and Diseases in Patients With and Without Leptin-Melanocortin Pathway. Mayo Clinic Proceedings (2023). Variants Lizeth Cifuentes, MD; Alejandro Campos, MD; Daniel Sacoto, MD; Wissam Ghusn, MD; Alan De la Rosa, MD; Fauzi Feris, MD; Alison McRea, MS; Joshua T. Bublitz, BS; Maria D. Hurtado, MD, PhD; Janet Olson, PhD; and Andres Acosta, MD, PhD. PMID:36549983
• Weight loss Outcomes of Semaglutide in Patients with Overweight and Obesity. JAMA Network Open (2022). Wissam Ghusn MD, Lizeth Cifuentes MD, Alejandro Campos MD, Daniel Sacoto MD, Alan De La Rosa MD, Fauzi Feris MD
• Sex as an Independent Variable in the Measurement of Satiation: A Retrospective Cohort Study. IJO (2022) Hurtado, Cifuentes L, Campos, A., De La Rosa, A., Kapoor, E., Faubion, S. S & Acosta, A. Y. Available at SSRN3923252.
• The Effects of Heterozygous Variants in the Leptin-Melanocortin Pathway on Roux-En-Y Gastric Bypass Surgery Outcomes: A15-Year Follow-Up Case-Control Study. Obesity Surgery. Campos, A., Cifuentes, L., Hashem, A., Busbeee, B., Hurtado, MD., Ricardo-Silgado, M.D., McRae, A., De la Rosa, A., Feris, F, Bublitz, J., Hensrud, D., et al. (2023).
• Association between Food Intake and Gastrointestinal Symptoms in Patients with Obesity. Wissam Ghusn MD, Lizeth Cifuentes MD, Alejandro Campos MD, Daniel Sacoto MD, Alan De La Rosa MD, Fauzi Feris MD, Gerardo Calderon MD, Daniel Gonzalez Zundegui MD, Jessica Stutzman, Maria Daniela Hurtado MD, PhD, Michael Camilleri MD, PhD, Andres Acosta MD, PhD. Gastro Hep Adv.2023;2(1):121-128. doi:10.1016/j.gastha.2022.07.019. Epub2022 Aug7. PMID:36741967; PMCID: PMC9894313.
• Leptin-Melanocortin Pathway Mutations and Cardiovascular Morbidity in Patients with Obesity. Obesity Surgery (2021). Lizeth Cifuentes, Alejandro Campos, Alan De la Rosa, Anas Hashem, Maria Laura Ricardo Silgado, Bradley Busbeee Rochester, Joshua Bublitz, Maria Daniela Hurtado Andrade, Janet Olson, Andres Acosta
• Successful use of rivaroxaban achieving therapeutic anti-Factor Xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism. Kingsley Dah, Mateo Porres-Aguilar, Alan De la Rosa, Swathi Prakash. Vasc Bras.2023 Jun30;22:e20230056. DOI:10.1590/1677-5449.202300562. PMCID: PMC10421569
• A Case Report of Cytarabine-Induced Ear Syndrome. Bottros M, De La Rosa A, Nadella S, Chang AY, Maharaj SS.. Cureus.2023 Nov12;15(11):e48707. doi:10.7759/cureus.48707. PMID:38094566; PMCID: PMC10716602.zi
• Semaglutide Outcomes in NALD: A multicenter real world study. DOI:10.14309/01.ajg.0000955580.73643.8b
• Cardiovascular Disease Risk Improvement With Semaglutide in Patients With Obesity: A Multi-Centered Study. DOI:10.14309/01.ajg.0000956232.19702.5a
• Effect of Changes in Gastric Emptying and Low-Calorie Phenotype Tailored Diet on Weight Loss: Results From a12-week Clinical Trial DOI:10.14309/01.ajg.0000956168.75138.f0

• 02/2024 – to Present JACC reviewer in the field of : Cardiometabolic, Health promotion and preventive cardiology, Hypertension. Supervisor: Collin Grabarek. Managing Editor, JACC
• 03/2021 -06/2022 Mayo Clinic, Rochester, MN, United States of America Gastroenterology and Hepatology Post-doc Research Fellow, Mentors: Andres Acosta M.D., PhD and Maria Daniela Hurtado M.D., Ph.D.
• 07/2022 to Present Mayo Clinic External Collaborator Department of Hepatology and Gastroenterology. Precision Medicine for Obesity Laboratory. Mayo Clinic, Rochester, Mn.

BCLS

ACLS